Shares of Johnson Matthey PLC (LON:JMAT – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six research firms that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price objective among analysts that have covered the stock in the last year is GBX 2,283.33.
JMAT has been the subject of several research analyst reports. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 2,330 price objective on shares of Johnson Matthey in a report on Tuesday, August 4th. Berenberg Bank raised their price target on shares of Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the company a “buy” rating in a report on Monday, June 1st. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 2,400 price target on shares of Johnson Matthey in a research note on Monday, July 6th.
Get Our Latest Research Report on Johnson Matthey
Johnson Matthey Trading Up 0.4%
Insider Buying and Selling
In related news, insider Liam Condon bought 10,951 shares of the company’s stock in a transaction that occurred on Friday, September 11th. The shares were bought at an average price of GBX 2,306 per share, for a total transaction of £252,530.06. Also, insider Richard Pike bought 17,635 shares of the business’s stock in a transaction on Friday, September 11th. The stock was bought at an average cost of GBX 2,248 per share, with a total value of £396,434.80. Over the last quarter, insiders have purchased 28,636 shares of company stock worth $64,995,344. 0.74% of the stock is owned by insiders.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Stories
- Five stocks we like better than Johnson Matthey
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
